1. Home
  2. IVDA vs XRTX Comparison

IVDA vs XRTX Comparison

Compare IVDA & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iveda Solutions Inc.

IVDA

Iveda Solutions Inc.

HOLD

Current Price

$0.88

Market Cap

4.5M

Sector

Technology

ML Signal

HOLD

Logo XORTX Therapeutics Inc.

XRTX

XORTX Therapeutics Inc.

HOLD

Current Price

$0.61

Market Cap

4.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IVDA
XRTX
Founded
2003
2011
Country
United States
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
4.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IVDA
XRTX
Price
$0.88
$0.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.2M
50.0K
Earning Date
11-14-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,395,926.00
N/A
Revenue This Year
$340.48
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
20.56
N/A
52 Week Low
$0.61
$0.52
52 Week High
$8.05
$1.79

Technical Indicators

Market Signals
Indicator
IVDA
XRTX
Relative Strength Index (RSI) 41.04 46.07
Support Level $1.11 $0.61
Resistance Level $1.37 $0.67
Average True Range (ATR) 0.16 0.03
MACD -0.01 0.00
Stochastic Oscillator 10.59 22.06

Price Performance

Historical Comparison
IVDA
XRTX

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

Share on Social Networks: